Dianthus Therapeutics, Inc. /DE/ Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -9.43M-35.49M-57.52M-76.77M-28.56M-43.41M-84.50M
Depreciation and Depletion 0.03M0.07M0.10M
Share-based Compensation 0.66M2.26M10.70M10.00M9.94M10.31M1.52M2.90M12.89M
Gains from Sales and Divestitures 0.91M0.08M0.01M
Gains from Investment Securities 0.62M3.51M-0.00M1.30M0.53M1.75M4.50M
Non-cash Items 1.79M0.57M3.64M3.18M24.87M
Cash from Operations -6.53M-22.26M-41.89M-57.10M-64.02M-59.53M-29.07M-36.86M-78.18M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.19M1.01M-0.18M-0.71M0.61M1.42M6.02M
Amortization of Deferred Charges 0.16M
Depreciation & Amortization (CF) 0.01M0.38M0.88M1.84M2.00M2.02M1.93M0.07M0.10M
Change in Working Capital
Change in Account Payables 1.01M-1.12M2.50M0.14M0.95M-0.72M-0.80M0.66M8.19M
Change in Accured Expenses 0.63M3.34M2.24M5.09M-3.63M0.15M0.97M
Investing Activities
Capital Expenditures 0.38M2.20M7.67M3.06M0.40M1.26M0.14M0.11M0.10M
Sales of Property, Plant and Equipment 0.01M
Change in Acquisitions & Divestments 148.96M85.50M90.00M2.00M77.78M127.00M
Cash from Investing Activities -0.14M-2.20M-91.70M1.53M-10.63M43.43M-59.82M20.25M-286.81M
Financing Activities
Other financing activities 0.21M3.09M0.60M0.30M0.30M14.66M
Debt Issuance and Repayment
Long-Term Debt Issuances 6.50M0.38M
Long-Term Debt Repayments 0.38M
Change in Capital Stock
Shares Issued 93.00M60.87M64.86M86.40M0.01M39.20M
Preferred Shares Issued 4.30M71.69M52.30M100.00M
Misc.
Cash from Financing Activities 10.71M71.49M142.15M62.30M67.74M89.60M96.68M133.57M255.62M
Change in Cash 4.04M47.02M8.56M6.73M-6.92M73.50M7.79M116.97M-109.37M
Free Cash Flow -6.90M-24.46M-49.56M-60.16M-64.42M-60.80M-29.21M-36.97M-78.28M
Net Cash Flow 4.04M47.02M8.56M6.73M-6.92M73.50M7.79M116.97M-109.37M